Sun Yat-sen University Cancer Center

News

The Latest Results of a First-in-class Claudin 18.2-specific...

November 02, 2023

On November 8, 2023, from 4:00 to 5:00 AM (Beijing Time), Dr. Rui-Hua Xu, professor of Medical Oncology and President of...
High quality clinical trials at Sun Yat-sen University Cance...

November 02, 2023

On October 27, 2023, the Food and Drug Administration approved toripalimab-tpzi (LOQTORZ) with cisplatin and gemcitabine...
Prof. Xu Ruihua from Sun Yat-sen University Cancer Center ga...

October 24, 2023

In the afternoon of October 21, 2023, Prof. Xu Ruihua from Sun Yat-sen University Cancer Center gave an oral presentatio...
Prof. Gao Song and Prof. Han Hui’s research group achieved n...

October 19, 2023

The loss of T cell effector function in the tumor microenvironment is one of the main reasons for immunotherapy failure....

< 3 4 5 6 7 >